Home・Elenco Azioni・OPKO Health Inc

OPKO Health Inc

Chiusa

SettoreSettore sanitario

1.6 -3.61

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.6099999999999999

Massimo

1.72

Metriche Chiave
By Trading Economics
Entrata	46M -8.4M
Vendite	39M 164M
EPS	-0.01
Margine di Profitto	-5.145
Dipendenti	2,275
EBITDA	43M 15M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+85.74% upside

Dividendi
By Acuity
Utili prossimi	28 ott 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	295M 1.2B
Apertura precedente	5.21
Chiusura precedente	1.6

OPKO Health Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

20 ott 2026, 23:06 UTC

OPKO Health Inc shares advanced modestly in after-market trading, remaining well above its 20-day moving average and near the upper end of its one-month range.

19 ott 2026, 23:01 UTC

OPKO Health Inc shares declined in after-market trading, continuing a downward trend as the NAHB Housing Market Index fell to 29, the lowest since June 2012.

16 ott 2026, 23:51 UTC

OPKO Health Inc shares declined during after-market hours, falling significantly after initially showing positive returns and remaining below their 20-day moving average.

15 ott 2026, 23:32 UTC

OPKO Health Inc's shares advanced during after-market hours on Thursday, diverging from a recent trend of higher daily closes despite currently trading lower.

14 ott 2026, 20:07 UTC

OPKO Health Inc. is advancing during Wednesday's trading session, rebounding significantly after an initial dip amid notably positive broader market performance.

13 ott 2026, 19:31 UTC

OPKO Health Inc shares fell sharply, currently at their lowest point of the day and well below the 20-day moving average, continuing a decline since Monday.

12 ott 2026, 20:06 UTC

OPKO Health Inc shares are modestly lower, ending near the lower end of their one-month trading range and significantly below the 20-day moving average.

9 ott 2026, 22:01 UTC

OPKO Health Inc declined sharply in after-market trading, moving well below its 20-day moving average and near the lower end of its one-month range.

8 ott 2026, 20:13 UTC

OPKO Health Inc shares advanced during after-market hours.

7 ott 2026, 20:00 UTC

OPKO Health Inc shares fell sharply, reaching their lowest point of the day and trading well below the 20-day moving average amid ongoing market weakness.

6 ott 2026, 22:20 UTC

OPKO Health Inc saw a notable increase in after-market trading, recovering from an initial dip and marking its highest cumulative return since Tuesday's close.

5 ott 2026, 20:06 UTC

OPKO Health Inc closed higher on Monday, showing a modest advance and peaking in late morning, while remaining around the midpoint of its one-month trading range.

3 ott 2026, 00:01 UTC

OPKO Health Inc is trading lower in after-market hours, continuing a trend of four consecutive sessions finishing lower amid ongoing performance weakness.

2 ott 2026, 23:41 UTC

OPKO Health Inc is trading lower in after-market hours, continuing a trend of declines following a sharp drop from its peak shortly after the market closed.

1 ott 2026, 20:02 UTC

OPKO Health Inc shares fell sharply, trading well below its 20-day moving average and near the lower end of its one-month range.

29 set 2026, 20:07 UTC

OPKO Health Inc is trading modestly higher, currently around the midpoint of its one-month range and above its 20-day moving average.

28 set 2026, 19:46 UTC

OPKO Health Inc shares fell amid a broader market decline, remaining above the 20-day moving average and around the midpoint of its one-month range.

25 set 2026, 20:07 UTC

OPKO Health Inc is trading higher amid a broader market rally, which closed above its 20-day moving average despite ongoing economic concerns.

24 set 2026, 23:01 UTC

OPKO Health Inc is trading modestly higher in after-market hours, rebounding from three consecutive lower daily closes amid mixed performance in the health care services sector.

23 set 2026, 21:50 UTC

OPKO Health Inc declined in after-market trading, shifting from a positive return to a negative one since Wednesday's close, settling at the day's lowest point.

22 set 2026, 23:01 UTC

OPKO Health Inc is trading lower in after-market hours, declining notably from its peak, amid concerns following the unexpected drop in the Richmond Fed Manufacturing Index.

21 set 2026, 23:10 UTC

OPKO Health Inc's shares declined modestly in after-market trading on Monday, falling to their lowest point of the day despite remaining above the 20-day moving average.

17 set 2026, 20:07 UTC

OPKO Health Inc's stock is roughly flat, remaining above its 20-day moving average and near the upper end of its one-month trading range.

16 set 2026, 19:03 UTC

OPKO Health Inc is seeing upward movement, currently trading significantly above its 20-day moving average and near the upper end of its one-month range.

15 set 2026, 23:11 UTC

OPKO Health Inc shares are higher in after-market trading, advancing from a low of 1.28% to a high of 1.92% since Tuesday's close.

14 set 2026, 20:08 UTC

News

OPKO Health has expanded its financing with HealthCare Royalty, securing $125 million in senior secured notes linked to future royalty payments in China.

11 set 2026, 20:01 UTC

OPKO Health Inc shares are higher, continuing gains since Thursday's close. The stock rebounded after an early dip, with no specific news driving the movement.

9 set 2026, 19:16 UTC

OPKO Health Inc. shares are lower today amid broader market pressures from rising oil prices above $100 per barrel and inflation concerns.

8 set 2026, 23:36 UTC

No specific news was identified for OPKO Health Inc. Shares traded roughly flat after market hours, remaining near the upper end of their one-month range.

4 set 2026, 20:07 UTC

OPKO Health Inc. shares are higher today, rebounding significantly after an initial dip and currently 12.75% above the 20-day moving average.

Confronto tra pari

Modifica del prezzo

OPKO Health Inc Previsione

Obiettivo di Prezzo

By TipRanks

85.74% in crescita

Previsioni per 12 mesi

Media 3.083 USD 85.74%

Alto 4 USD

Basso 2.25 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per OPKO Health Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 3 che hanno fornito valutazioni azionarie a OPKO Health Inc - Dist negli ultimi 3 mesi.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.